Intensive transfusion therapy in thalassemia major: an eight-year follow-up.
D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000328:Adult; D000365:Age Determination by Skeleton; D000367:Age Factors; D001793:Blood Preservation; D001803:Blood Transfusion; D002648:Child; D004562:Electrocardiography; D004912:Erythrocytes; D005080:Exercise Test; D005260:Female; D005500:Follow-Up Studies; D005615:Freezing; D005951:Glucose Tolerance Test; D006128:Growth; D006321:Heart / Q000503:physiopathology; D006432:Hemochromatosis / Q000209:etiology; D006801:Humans; D006914:Hydroxysteroids / Q000652:urine; D008099:Liver / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D013902:Radiography, Thoracic; D012727:Sex Characteristics; D013789:Thalassemia / Q000628:therapy*
D015068:17-Ketosteroids; D006914:Hydroxysteroids